WO2005077962A3 - Crowned dithiocarbamate metal complexes and methods for their use - Google Patents
Crowned dithiocarbamate metal complexes and methods for their use Download PDFInfo
- Publication number
- WO2005077962A3 WO2005077962A3 PCT/US2005/004872 US2005004872W WO2005077962A3 WO 2005077962 A3 WO2005077962 A3 WO 2005077962A3 US 2005004872 W US2005004872 W US 2005004872W WO 2005077962 A3 WO2005077962 A3 WO 2005077962A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- crowned
- methods
- complexes
- dtcs
- metal complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/0412—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K51/0423—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0476—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
- C07F13/005—Compounds without a metal-carbon linkage
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/588,343 US20070166227A1 (en) | 2004-02-10 | 2005-02-10 | Crowned dithiocarbamate metal complexes and methods for their use |
EP05726497A EP1718656A2 (en) | 2004-02-10 | 2005-02-10 | Crowned dithiocarbamate metal complexes and methods for their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54317604P | 2004-02-10 | 2004-02-10 | |
US60/543,176 | 2004-02-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005077962A2 WO2005077962A2 (en) | 2005-08-25 |
WO2005077962A3 true WO2005077962A3 (en) | 2005-12-15 |
Family
ID=34860386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/004872 WO2005077962A2 (en) | 2004-02-10 | 2005-02-10 | Crowned dithiocarbamate metal complexes and methods for their use |
Country Status (3)
Country | Link |
---|---|
US (1) | US20070166227A1 (en) |
EP (1) | EP1718656A2 (en) |
WO (1) | WO2005077962A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8282967B2 (en) | 2005-05-27 | 2012-10-09 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
US8981139B2 (en) | 2011-02-28 | 2015-03-17 | The University Of North Carolina At Chapel Hill | Tertiary S-nitrosothiol-modified nitric—oxide-releasing xerogels and methods of using the same |
US9526738B2 (en) | 2009-08-21 | 2016-12-27 | Novan, Inc. | Topical gels and methods of using the same |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8909325B2 (en) | 2000-08-21 | 2014-12-09 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
US8489176B1 (en) | 2000-08-21 | 2013-07-16 | Spectrum Dynamics Llc | Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures |
US8565860B2 (en) | 2000-08-21 | 2013-10-22 | Biosensors International Group, Ltd. | Radioactive emission detector equipped with a position tracking system |
WO2005119025A2 (en) | 2004-06-01 | 2005-12-15 | Spectrum Dynamics Llc | Radioactive-emission-measurement optimization to specific body structures |
US8036731B2 (en) | 2001-01-22 | 2011-10-11 | Spectrum Dynamics Llc | Ingestible pill for diagnosing a gastrointestinal tract |
IL157007A0 (en) | 2001-01-22 | 2004-02-08 | Target Technologies Ltd V | Ingestible device |
WO2007054935A2 (en) | 2005-11-09 | 2007-05-18 | Spectrum Dynamics Llc | Dynamic spect camera |
WO2007010534A2 (en) | 2005-07-19 | 2007-01-25 | Spectrum Dynamics Llc | Imaging protocols |
US9040016B2 (en) | 2004-01-13 | 2015-05-26 | Biosensors International Group, Ltd. | Diagnostic kit and methods for radioimaging myocardial perfusion |
US9470801B2 (en) | 2004-01-13 | 2016-10-18 | Spectrum Dynamics Llc | Gating with anatomically varying durations |
US7968851B2 (en) | 2004-01-13 | 2011-06-28 | Spectrum Dynamics Llc | Dynamic spect camera |
US8586932B2 (en) | 2004-11-09 | 2013-11-19 | Spectrum Dynamics Llc | System and method for radioactive emission measurement |
US8571881B2 (en) | 2004-11-09 | 2013-10-29 | Spectrum Dynamics, Llc | Radiopharmaceutical dispensing, administration, and imaging |
CN1981210A (en) | 2004-01-13 | 2007-06-13 | 光谱动力学有限责任公司 | Multi-dimensional image reconstruction |
EP1766550A2 (en) * | 2004-06-01 | 2007-03-28 | Spectrum Dynamics LLC | Methods of view selection for radioactive emission measurements |
TWI359810B (en) | 2004-11-04 | 2012-03-11 | Mitsubishi Tanabe Pharma Corp | Carboxylic acid derivative containing thiazole rin |
US8000773B2 (en) | 2004-11-09 | 2011-08-16 | Spectrum Dynamics Llc | Radioimaging |
US9943274B2 (en) | 2004-11-09 | 2018-04-17 | Spectrum Dynamics Medical Limited | Radioimaging using low dose isotope |
EP1827505A4 (en) | 2004-11-09 | 2017-07-12 | Biosensors International Group, Ltd. | Radioimaging |
US8615405B2 (en) | 2004-11-09 | 2013-12-24 | Biosensors International Group, Ltd. | Imaging system customization using data from radiopharmaceutical-associated data carrier |
US9316743B2 (en) | 2004-11-09 | 2016-04-19 | Biosensors International Group, Ltd. | System and method for radioactive emission measurement |
WO2008059489A2 (en) | 2006-11-13 | 2008-05-22 | Spectrum Dynamics Llc | Radioimaging applications of and novel formulations of teboroxime |
US7872235B2 (en) * | 2005-01-13 | 2011-01-18 | Spectrum Dynamics Llc | Multi-dimensional image reconstruction and analysis for expert-system diagnosis |
US8837793B2 (en) | 2005-07-19 | 2014-09-16 | Biosensors International Group, Ltd. | Reconstruction stabilizer and active vision |
US8111886B2 (en) | 2005-07-19 | 2012-02-07 | Spectrum Dynamics Llc | Reconstruction stabilizer and active vision |
EP1966984A2 (en) | 2005-12-28 | 2008-09-10 | Starhome GmbH | Optimal voicemail deposit for roaming cellular telephony |
US8894974B2 (en) | 2006-05-11 | 2014-11-25 | Spectrum Dynamics Llc | Radiopharmaceuticals for diagnosis and therapy |
GB0623482D0 (en) | 2006-11-24 | 2007-01-03 | Mallinckrodt Inc | Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging |
US9275451B2 (en) | 2006-12-20 | 2016-03-01 | Biosensors International Group, Ltd. | Method, a system, and an apparatus for using and processing multidimensional data |
EP2142284A4 (en) * | 2007-03-31 | 2015-12-23 | Advanced Applied Physics Solutions Inc | Method and apparatus for isolating 186rhenium |
US8521253B2 (en) | 2007-10-29 | 2013-08-27 | Spectrum Dynamics Llc | Prostate imaging |
CU23844B1 (en) * | 2009-04-17 | 2012-10-15 | Ct De Neurociencias De Cuba | PROCEDURE FOR OBTAINING NEW DERIVATIVES OF NAFTALENE FOR THE LIVE DIAGNOSIS OF ALZHEIMER'S DISEASE |
US8338788B2 (en) | 2009-07-29 | 2012-12-25 | Spectrum Dynamics Llc | Method and system of optimized volumetric imaging |
WO2011022680A2 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Wound dressings, methods of using the same and methods of forming the same |
US9587292B2 (en) | 2009-10-01 | 2017-03-07 | Advanced Applied Physics Solutions, Inc. | Method and apparatus for isolating the radioisotope molybdenum-99 |
CN106588729B (en) * | 2016-12-06 | 2021-05-28 | 青岛柏森环保工程有限公司 | Preparation method of polythiohydrazide type heavy metal chelating agent |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322771B1 (en) * | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
-
2005
- 2005-02-10 US US10/588,343 patent/US20070166227A1/en not_active Abandoned
- 2005-02-10 EP EP05726497A patent/EP1718656A2/en not_active Withdrawn
- 2005-02-10 WO PCT/US2005/004872 patent/WO2005077962A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6322771B1 (en) * | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
Non-Patent Citations (9)
Title |
---|
CAMERON, B ET AL.: "Ruthenium (III) Triazacyclononane Dithiocarbamate...", INORGANIC CHEMISTRY, vol. 42, no. 13, 2003, pages 4102 - 4108, XP002335490 * |
DATABASE BEILSTEIN [online] BEILSTEIN INSTITUTE FOR ORGANIC CHEMISTRY, FRANKFURT-MAIN, DE; 23 October 1991 (1991-10-23), XP002332644, Database accession no. BRN 3580252; BRN3582715 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; BERRY, NEIL G. ET AL: "Heteroditopic transition metal dithiocarbamate receptors for binding cation-anion ion pairs", XP002332544, retrieved from STN Database accession no. 2003:732428 * |
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; GRANELL, JAUME ET AL: "Studies on the synthesis and electrochemistry of crown ether dithiocarbamates and the molecular dynamics of bis(aza-15-crown- 5)thiuram disulfide. Crystal structure of cobalt tris[(aza-15-crown-5)dithiocarbamate]", XP002332545, retrieved from STN Database accession no. 1990:490225 * |
DIAZ ET AL.: "Interactions of nitric ocide with copper (II) dithiocarbamates in aqueous solution", JOURNAL OF INORGANIC BIOCHEMISTRY, no. 95, 2003, pages 283 - 290, XP002335489 * |
JOURNAL OF SUPRAMOLECULAR CHEMISTRY , VOLUME DATE 2002, 2(1-3), 89-92 CODEN: JSCOC9; ISSN: 1472-7862, 2003 * |
JOURNAL OF THE CHEMICAL SOCIETY, DALTON TRANSACTIONS: INORGANIC CHEMISTRY (1972-1999) , (2), 605-14 CODEN: JCDTBI; ISSN: 0300-9246, 1990 * |
SCHRAMM D ET AL: "SYNTHESIS OF CATIONIC HYDROTRIS(PYRAZOLYL)BORATE ZIRCONIUM COMPOUNDS", INTERNATIONAL CONFERENCE ON ORGANOMETALLIC CHEMISTRY. BOOK OF ABSTRACTS, 16 August 1998 (1998-08-16), pages A150, XP002249590 * |
VÖGTLE, FRITZ, NEUMANN, PETER: "Stereochemie im Innern cyclischer Verbindungen: Kronenäther, Katapinate und Kryptate", CHEMIKER-ZEITUNG, vol. 97, no. 11, 1973, pages 600 - 610, XP002335491 * |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8282967B2 (en) | 2005-05-27 | 2012-10-09 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US8956658B2 (en) | 2005-05-27 | 2015-02-17 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US8962029B2 (en) | 2005-05-27 | 2015-02-24 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US9403851B2 (en) | 2005-05-27 | 2016-08-02 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US9403852B2 (en) | 2005-05-27 | 2016-08-02 | The University Of North Carolina At Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
US9526738B2 (en) | 2009-08-21 | 2016-12-27 | Novan, Inc. | Topical gels and methods of using the same |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
US8981139B2 (en) | 2011-02-28 | 2015-03-17 | The University Of North Carolina At Chapel Hill | Tertiary S-nitrosothiol-modified nitric—oxide-releasing xerogels and methods of using the same |
Also Published As
Publication number | Publication date |
---|---|
US20070166227A1 (en) | 2007-07-19 |
WO2005077962A2 (en) | 2005-08-25 |
EP1718656A2 (en) | 2006-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005077962A3 (en) | Crowned dithiocarbamate metal complexes and methods for their use | |
IL258880A (en) | Diarylhydantoin compounds | |
WO2007076085A3 (en) | Fused pyrimidones and thiopyrimidones, and uses thereof | |
WO2004063355A3 (en) | Novel methods of diagnosis of metastatic cancer, compositions and methods of screening for modulators of matastatic cancer | |
WO2003008583A3 (en) | Novel compositions and methods for cancer | |
WO2008092590A3 (en) | Particulate uv protection agent | |
AU2003300368A8 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
EA200700501A1 (en) | COMPOSITION (OPTIONS) AND METHOD FOR THE TREATMENT OF HYPERPROLIFERATIVE PROCESSES, METHOD OF TREATING CANCER (OPTIONS) AND METHOD OF OBTAINING SOLID DISPERSION OF THE SUBSTANCE | |
WO2005085266A8 (en) | Macrocyclic compounds and methods of making and using the same | |
WO2007044413A3 (en) | Wwox gene, vectors containing the same, and uses in treatment of cancer | |
WO2006083533A3 (en) | Compositions and methods for inhibiting drusen formation and for diagnosing or treating drusen-related disorders | |
WO2006017295A3 (en) | Tetrapeptide analogs | |
WO2004071382A3 (en) | Substituted heterocycles | |
WO2006091457A3 (en) | Ionic liquids derived from peracid anions | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
WO2010065329A3 (en) | Nanoparticles for cancer treatment | |
MX2017009091A (en) | Desferrioxamine-metal complexes for the treatment of immune-related disorders. | |
WO2011140232A3 (en) | Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents | |
WO2005049520A3 (en) | Method for solubilizing metal oxides by surface treatment, surface treated metal oxide solutions and method for separating metal oxides | |
WO2003045230A3 (en) | Novel compositions and methods for cancer | |
WO2007022307A3 (en) | Ligands for metal ions and methods for making and using the same | |
WO2005082008A3 (en) | Methods for diagnosing and treating bladder cancer | |
WO2006078336A3 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
EP1728765A4 (en) | Anatase-type titanium oxide powder and method for producing same | |
WO2010072770A3 (en) | Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007166227 Country of ref document: US Ref document number: 10588343 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005726497 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005726497 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10588343 Country of ref document: US |